← Open Payments lookup

ANGELA BIEMAN: Open Payments

NPI 1386294635 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$306 in 19 payments from 6 companies in 2025. Trend: 2023 $180 · 2024 $416 · 2025 $306

Food & beverage: $306
CompanyPaymentsAmount
GlaxoSmithKline, LLC.6$102
ABBVIE INC.5$82
Madrigal Pharmaceuticals4$58
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$29
Blueprint Medicines Corporation1$18
ViiV Healthcare Company1$17

Products named: TRELEGY ELLIPTA, RINVOQ, REZDIFFRA, XIFAXAN, SKYRIZI, AYVAKIT, APRETUDE, NUCALA.

Industry payments across NJ — which companies pay providers there.